サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1356754

乳房生検装置市場レポート：2030年までの動向、予測、競合分析

Breast Biopsy Device Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日: | 発行: Lucintel | ページ情報: 英文 150 Pages | 納期: 3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円

ご注意:　DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

乳房生検装置市場レポート：2030年までの動向、予測、競合分析
出版日: 2023年09月01日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

乳房生検装置の動向と予測

世界の乳房生検装置市場は、2024年から2030年までのCAGRが5.2%で、2030年までに推定21億米ドルに達すると予測されます。この市場の主な促進要因は、乳がん罹患率の増加、より低侵襲な手技を可能にする本装置の大幅な使用、リキッド生検への嗜好の高まりです。世界の乳房生検装置市場の将来は、病院・診療所、研究所、製薬・バイオテクノロジー市場でのビジネスチャンスにより有望視されています。

乳房生検装置市場の洞察

Lucintelの予測では、ガイダンスシステムは生検手技の精度と効率を高めるために重要な用途であるため、予測期間中に最も高い成長が見込まれます。

病院は、患者ケアを改善するための高度な診断ツールや熟練した専門家の採用が増加しているため、最大セグメントであり続けると思われます。

北米は、乳がん患者の増加、魅力的な償還機会の提供、同地域の強固なヘルスケアインフラの存在により、予測期間中に最も高い成長が見込まれます。

本レポートでは、以下の11の主要な質問に回答している：

  • Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か？
  • Q.2.どのセグメントがより速いペースで成長するのか、またその理由は？
  • Q.3.今後成長が加速すると思われる地域とその理由は？
  • Q.4.市場力学に影響を与える主な要因は何か？市場における主な課題とビジネスリスクは？
  • Q.5.この市場におけるビジネスリスクと競合の脅威は？
  • Q.6.この市場における新たな動向とその理由は？
  • Q.7.市場における顧客の需要の変化にはどのようなものがありますか？
  • Q.8.この市場における新たな開発と、その開発をリードしている企業は？
  • Q.9.この市場における主要企業は？主要企業は事業成長のためにどのような戦略的取り組みを進めているのか？
  • Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度ありますか？
  • Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えましたか？

目次

第1章 エグゼクティブサマリー

第2章 世界の乳房生検装置市場：市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

  • マクロ経済動向（2018～2023年）と予測（2024～2030年）
  • 世界の乳房生検装置市場動向（2018-2023）と予測（2024-2030）
  • タイプ別の世界の乳房生検装置市場
    • 生検針
    • 誘導システム
    • 生検台
    • ローカリゼーションワイヤー
    • アッセイキット
    • リキッドバイオプシー器具
    • その他
  • 手順別の世界の乳房生検装置市場
    • 乳房針生検
    • 開腹外科的乳房生検
    • 液体乳房生検
  • アプリケーション別の世界の乳房生検装置市場
    • 早期がん検診
    • 治療法の選択
    • 治療のモニタリング
    • 再発のモニタリング
  • 最終用途別の世界の乳房生検装置市場
    • 病院とクリニック
    • 調査
    • 製薬およびバイオテクノロジー企業
    • その他

第4章 2018年から2030年までの地域別の市場動向と予測分析

  • 地域別の世界の乳房生検装置市場
  • 北米の乳房生検装置市場
  • 欧州の乳房生検装置市場
  • アジア太平洋乳房生検装置市場
  • その他地域乳房生検装置市場

第5章 競合の分析

  • 製品ポートフォリオ分析
  • 運用上の統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

  • 成長機会分析
    • タイプ別の世界の乳房生検装置市場の成長機会
    • 手順別の世界の乳房生検装置市場の成長機会
    • アプリケーション別の世界の乳房生検装置市場の成長機会
    • 最終用途別の世界の乳房生検装置市場の成長機会
    • 地域別の世界の乳房生検装置市場の成長機会
  • 世界の乳房生検装置市場の新たな動向
  • 戦略的分析
    • 新製品の開発
    • 世界の乳房生検装置市場の能力拡大
    • 世界の乳房生検装置市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 有力企業の企業プロファイル

  • Hologic
  • Danaher
  • Argon Medical Devices
  • Merit Medical Systems
  • Menarini-Silicon Biosystems
  • Guardant Health
  • NeoGenomics
  • Sysmex Inostics
  • Sterylab
  • Biocept
目次

Breast Biopsy Device Trends and Forecast

The future of the global breast biopsy device market looks promising with opportunities in the hospital & clinic, research laboratory, and pharmaceutical & biotechnology markets. The global breast biopsy device market is expected to reach an estimated $2.1 billion by 2030 with a CAGR of 5.2% from 2024 to 2030. The major drivers for this market are growing incidence of breast cancer, significant use of this device to enable less intrusive techniques, and rising preference for liquid biopsy.

A more than 150-page report is developed to help in your business decisions.

Breast Biopsy Device by Segment

The study includes a forecast for the global breast biopsy device by type, procedure, application, end use, and region.

Breast Biopsy Device Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Biopsy Needles
  • Guidance Systems
  • Biopsy Tables
  • Localization Wires
  • Assay Kits
  • Liquid Biopsy Instruments
  • Others

Breast Biopsy Device Market by Procedure [Shipment Analysis by Value from 2018 to 2030]:

  • Needle Breast Biopsy
  • Open Surgical Breast Biopsy
  • Liquid Breast Biopsy

Breast Biopsy Device Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Early Cancer Screening
  • Therapy Selection
  • Treatment Monitoring
  • Recurrence Monitoring

Breast Biopsy Device Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals & Clinics
  • Research Laboratories
  • Pharmaceutical & Biotechnology Companies
  • Others

Breast Biopsy Device Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Breast Biopsy Device Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies breast biopsy device companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the breast biopsy device companies profiled in this report include-

  • Hologic
  • Danaher
  • Argon Medical Devices
  • Merit Medical Systems
  • Menarini-Silicon Biosystems
  • Guardant Health
  • Neogenomics
  • Sysmex Inostics
  • Sterylab
  • Biocept

Breast Biopsy Device Market Insights

Lucintel forecasts that guidance system is expected to witness highest growth over the forecast period due to its significant use in enhancing the accuracy and efficiency of biopsy procedures.

Hospital will remain the largest segment due to the rising adoption of advanced diagnostic tools and skilled professionals to improve patient care in this setting.

North America is expected to witness highest growth over the forecast period due to rising breast cancer cases, availability of attractive reimbursement opportunities, and presence of robust healthcare infrastructure in the region.

Features of the Global Breast Biopsy Device Market

Market Size Estimates: Breast biopsy device market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Breast biopsy device market by various segments, such as by type, procedure, application, end use and region in terms of($B).

Regional Analysis: Breast biopsy device market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, procedures, applications, end uses, and region.s for the breast biopsy device market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the breast biopsy device market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1. What is the breast biopsy device market size?

Answer: The global breast biopsy device market is expected to reach an estimated $2.1 billion by 2030.

Q.2. What is the growth forecast for breast biopsy device market?

Answer: The global breast biopsy device market is expected to grow with a CAGR of 5.2% from 2024 to 2030.

Q.3. What are the major drivers influencing the growth of the breast biopsy device market?

Answer: The major drivers for this market are growing incidence of breast cancer, significant use of this device to enable less intrusive techniques, and rising preference for liquid biopsy.

Q.4. What are the major segments for breast biopsy device market?

Answer: The future of the breast biopsy device market looks promising with opportunities in the hospital & clinic, research laboratory, and pharmaceutical & biotechnology markets.

Q.5. Who are the key breast biopsy device market companies?

Answer: Some of the key breast biopsy device companies are as follows:

  • Hologic
  • Danaher
  • Argon Medical Devices
  • Merit Medical Systems
  • Menarini-Silicon Biosystems
  • Guardant Health
  • NeoGenomics
  • Sysmex Inostics
  • Sterylab
  • Biocept

Q.6. Which breast biopsy device market segment will be the largest in future?

Answer: Lucintel forecasts that guidance system is expected to witness highest growth over the forecast period due to its significant use in enhancing the accuracy and efficiency of biopsy procedures.

Q.7. In breast biopsy device market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to rising breast cancer cases, availability of attractive reimbursement opportunities, and presence of robust healthcare infrastructure in the region.

Q.8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the breast biopsy device market by type (biopsy needles, guidance systems, biopsy tables, localization wires, assay kits, liquid biopsy instruments, and others), procedure (needle breast biopsy, open surgical breast biopsy, and liquid breast biopsy), application (early cancer screening, therapy selection, treatment monitoring, and recurrence monitoring), end use (hospitals & clinics, research laboratories, pharmaceutical & biotechnology companies, and others), and region. (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Breast Biopsy Device Market: Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Breast Biopsy Device Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Breast Biopsy Device Market by Type
    • 3.3.1: Biopsy Needles
    • 3.3.2: Guidance Systems
    • 3.3.3: Biopsy Tables
    • 3.3.4: Localization Wires
    • 3.3.5: Assay Kits
    • 3.3.6: Liquid Biopsy Instruments
    • 3.3.7: Others
  • 3.4: Global Breast Biopsy Device Market by Procedure
    • 3.4.1: Needle Breast Biopsy
    • 3.4.2: Open Surgical Breast Biopsy
    • 3.4.3: Liquid Breast Biopsy
  • 3.5: Global Breast Biopsy Device Market by Application
    • 3.5.1: Early Cancer Screening
    • 3.5.2: Therapy Selection
    • 3.5.3: Treatment Monitoring
    • 3.5.4: Recurrence Monitoring
  • 3.6: Global Breast Biopsy Device Market by End Use
    • 3.6.1: Hospitals & Clinics
    • 3.6.2: Research Laboratories
    • 3.6.3: Pharmaceutical & Biotechnology Companies
    • 3.6.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Breast Biopsy Device Market by Region
  • 4.2: North American Breast Biopsy Device Market
    • 4.2.2: North American Breast Biopsy Device Market by End Use: Hospitals & Clinics, Research Laboratories, Pharmaceutical & Biotechnology Companies, and Others
  • 4.3: European Breast Biopsy Device Market
    • 4.3.1: European Breast Biopsy Device Market by Type: Biopsy Needles, Guidance Systems, Biopsy Tables,Localization Wires, Assay Kits, Liquid Biopsy Instruments, and Others
    • 4.3.2: European Breast Biopsy Device Market by End Use: Hospitals & Clinics, Research Laboratories, Pharmaceutical & Biotechnology Companies, and Others
  • 4.4: APAC Breast Biopsy Device Market
    • 4.4.1: APAC Breast Biopsy Device Market by Type: Biopsy Needles, Guidance Systems, Biopsy Tables,Localization Wires, Assay Kits, Liquid Biopsy Instruments, and Others
    • 4.4.2: APAC Breast Biopsy Device Market by End Use: Hospitals & Clinics, Research Laboratories, Pharmaceutical & Biotechnology Companies, and Others
  • 4.5: ROW Breast Biopsy Device Market
    • 4.5.1: ROW Breast Biopsy Device Market by Type: Biopsy Needles, Guidance Systems, Biopsy Tables,Localization Wires, Assay Kits, Liquid Biopsy Instruments, and Others
    • 4.5.2: ROW Breast Biopsy Device Market by End Use: Hospitals & Clinics, Research Laboratories, Pharmaceutical & Biotechnology Companies, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Breast Biopsy Device Market by Type
    • 6.1.2: Growth Opportunities for the Global Breast Biopsy Device Market by Procedure
    • 6.1.3: Growth Opportunities for the Global Breast Biopsy Device Market by Application
    • 6.1.4: Growth Opportunities for the Global Breast Biopsy Device Market by End Use
    • 6.1.5: Growth Opportunities for the Global Breast Biopsy Device Market by Region
  • 6.2: Emerging Trends in the Global Breast Biopsy Device Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Breast Biopsy Device Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Breast Biopsy Device Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Hologic
  • 7.2: Danaher
  • 7.3: Argon Medical Devices
  • 7.4: Merit Medical Systems
  • 7.5: Menarini-Silicon Biosystems
  • 7.6: Guardant Health
  • 7.7: NeoGenomics
  • 7.8: Sysmex Inostics
  • 7.9: Sterylab
  • 7.10: Biocept